scholarly journals Meadow faces GMC over evidence given in child death cases

BMJ ◽  
2004 ◽  
Vol 328 (7433) ◽  
pp. 209-a-209
Keyword(s):  
BMJ ◽  
2004 ◽  
Vol 328 (7430) ◽  
pp. 9-9
Author(s):  
O. Dyer
Keyword(s):  

Crisis ◽  
2014 ◽  
Vol 35 (5) ◽  
pp. 292-300 ◽  
Author(s):  
Rebecca Soole ◽  
Kairi Kõlves ◽  
Diego De Leo

Background: Suicide among children under the age of 15 years is a leading cause of death. Aims: The aim of the current study is to identify demographic, psychosocial, and psychiatric factors associated with child suicides. Method: Using external causes of deaths recorded in the Queensland Child Death Register, a case-control study design was applied. Cases were suicides of children (10–14 years) and adolescents (15–17 years); controls were other external causes of death in the same age band. Results: Between 2004 and 2012, 149 suicides were recorded: 34 of children aged 10–14 years and 115 of adolescents aged 15–17 years. The gender asymmetry was less evident in child suicides and suicides were significantly more prevalent in indigenous children. Children residing in remote areas were significantly more likely to die by suicide than other external causes compared with children in metropolitan areas. Types of precipitating events differed between children and adolescents, with children more likely to experience family problems. Disorders usually diagnosed during infancy, childhood, and adolescence (e.g., ADHD) were significantly more common among children compared with adolescents who died by suicide. Conclusion: Psychosocial and environmental aspects of children, in addition to mental health and behavioral difficulties, are important in the understanding of suicide in this age group and in the development of targeted suicide prevention.


2010 ◽  
Vol 40 (2) ◽  
pp. 12
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  

PEDIATRICS ◽  
2016 ◽  
Vol 137 (Supplement 3) ◽  
pp. 42A-42A ◽  
Author(s):  
Theodore Trigylidas ◽  
Eliza Reynolds ◽  
Getachew Teshome ◽  
Heather Dykstra ◽  
Richard Lichenstein

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1390-1395
Author(s):  
Arafa Musa ◽  
Ehab M. Mostafa ◽  
Mohammad M. Al-Sanea ◽  
Shaimaa R. Ahmed ◽  
Gomaa Mostafa-Hedeab ◽  
...  

Natural polyphenolic drugs were approved for treatment of various diseases. Diosmin, rutin, quercetin, aesculin, genistein, hesperidin and silybin are known for their safety and have been applied for several human disorders including cancer, cardiovascular disorders, atherosclerosis, oxidative stress, capillary fragility, liver and pancreatic disorders and others. As the structures of the selected polyphenolic compounds possess variable chemical moieties with diverse chemical and electronic characters, these properties have been employed for further insights studies to predict new applications concerning the newly occurred pandemic. COVID-19 is a terrible disease that attacked millions of human populations at the end of year 2019. As the number of death cases has increased to exceed one million of humans, the early discovery of new treatment from previously approved and safe drugs is the main target of this study. Employing the putative docking studies for the selected polyphenolic drugs were done and the results were promising, all tested drugs exhibited high affinity with the selected five proteins of protease enzyme, the docking score ranged from -8.4461 to -26.1691 kcal/mol with 3-7 variable interaction bonds. Among the tested drugs, diosmin appeared as the most promising drug as it exhibited the highest energy score and interaction bonds with the most of proteins.


Sign in / Sign up

Export Citation Format

Share Document